Wolverine Trading
ARCT icon

Wolverine Trading’s Arcturus Therapeutics ARCT Stock Holding History

Wolverine Trading’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$225K Sell
12,000
-14,100
-54% -$227K ﹤0.01% 4787
2025
Q2 		$348K Buy
26,100
+15,700
+151% +$186K ﹤0.01% 3310
2025
Q1 		$120K Sell
10,400
-3,700
-26% -$58.7K ﹤0.01% 4165
2024
Q4 		$234K Buy
+14,100
New +$265K ﹤0.01% 4320
2024
Q1 		– Sell
-15,300
Closed -$482K – 4458
2023
Q4 		$482K Buy
15,300
+2,600
+20% +$61.8K ﹤0.01% 2987
2023
Q3 		$324K Sell
12,700
-6,700
-35% -$206K ﹤0.01% 3208
2023
Q2 		$516K Buy
+19,400
New +$528K ﹤0.01% 2571
2021
Q2 		– Sell
-13,000
Closed -$504K – 5878
2021
Q1 		$504K Sell
13,000
-15,200
-54% -$906K ﹤0.01% 3686
2020
Q4 		$1.32M Buy
28,200
+13,700
+94% +$928K ﹤0.01% 2101
2020
Q3 		$620K Buy
14,500
+6,700
+86% +$333K ﹤0.01% 2577
2020
Q2 		$366K Sell
7,800
-4,900
-39% -$169K ﹤0.01% 3093
2020
Q1 		$168K Buy
+12,700
New +$163K ﹤0.01% 3779
2017
Q2 		– Sell
-1,629
Closed -$13K – 4234
2017
Q1 		$13K Buy
+1,629
New +$15.1K ﹤0.01% 4115
2016
Q4 		– Sell
-5,171
Closed -$91K – 4409
2016
Q3 		$91K Sell
5,171
-1,143
-18% -$36.9K ﹤0.01% 4230
2016
Q2 		$192K Buy
+6,314
New +$199K ﹤0.01% 3309

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Wolverine Trading's ARCT Position: Q3 2025 in Review

Wolverine Trading increased its Arcturus Therapeutics (ARCT) stake by 5.5% in Q3 2025, buying an estimated $12.2K and bringing the position to 14,610 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #4514.

Wolverine Trading first reported a position in ARCT in Q2 2020 and has held it in 6 quarters since. The position peaked at $943K in Q2 2020. 136 funds tracked by Wall St. Rank hold ARCT as of Q3 2025.

  • Wolverine Trading held 14,610 shares of Arcturus Therapeutics worth $274K as of Q3 2025.
  • Wolverine Trading bought 760 Arcturus Therapeutics shares in Q3 2025, an estimated $12.2K.
  • Arcturus Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4514 holding.
  • Wolverine Trading first reported a position in Arcturus Therapeutics in Q2 2020 and has held it in 6 quarters since.
  • Wolverine Trading's Arcturus Therapeutics position peaked at $943K in Q2 2020.
  • 136 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.